Kaplan Matthew L. - Insider Non-Derivative Transactions at Nuvectis Pharma, Inc. (NVCT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 13, 2024, Kaplan Matthew L.'s relationship to Nuvectis Pharma, Inc. (NVCT) is Director, and currently has 83,760 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NVCT insiders.
Data Source: SEC.
Kaplan Matthew L. - Insider Non-Derivative Transactions of NVCT Common Stock
Kaplan Matthew L. - Insider Non-Derivative Transactions at NVCT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 14, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 83760 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 18000 | 0 | 53760 |